Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Session 2 - Optimal standard of Care

The art of optimal first-line therapy for patients with sensitizing or uncommon EGFR M+ lung cancer

Date

26 Jan 2024

Session

Session 2 - Optimal standard of Care

Topics

Pathology/Molecular Biology;  Targeted Therapy

Tumour Site

Thoracic Malignancies

Presenters

Tony S. K. Mok, HKSAR CN

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.